ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/06 | 2,350 | 2,408 | 2,350 | 2,401 | +40 | +1.7% | 795,000 |
2023/04/05 | 2,400 | 2,401 | 2,357 | 2,361 | -44 | -1.8% | 689,600 |
2023/04/04 | 2,405 | 2,479 | 2,400 | 2,405 | +50 | +2.1% | 1,547,500 |
2023/04/03 | 2,310 | 2,441 | 2,307 | 2,355 | +88 | +3.9% | 1,726,000 |
2023/03/31 | 2,259 | 2,283 | 2,242 | 2,267 | +17 | +0.8% | 459,700 |
2023/03/30 | 2,253 | 2,292 | 2,241 | 2,250 | +23 | +1% | 709,900 |
2023/03/29 | 2,213 | 2,247 | 2,202 | 2,227 | +11 | +0.5% | 672,700 |
2023/03/28 | 2,173 | 2,230 | 2,130 | 2,216 | +75 | +3.5% | 958,700 |
2023/03/27 | 2,150 | 2,150 | 2,105 | 2,141 | -26 | -1.2% | 909,700 |
2023/03/24 | 2,182 | 2,185 | 2,148 | 2,167 | -15 | -0.7% | 679,600 |
2023/03/23 | 2,183 | 2,186 | 2,137 | 2,182 | -41 | -1.8% | 1,502,700 |
2023/03/22 | 2,269 | 2,272 | 2,196 | 2,223 | -14 | -0.6% | 1,575,600 |
2023/03/20 | 2,395 | 2,402 | 2,236 | 2,237 | -175 | -7.3% | 1,822,300 |
2023/03/17 | 2,420 | 2,445 | 2,376 | 2,412 | +11 | +0.5% | 747,200 |
2023/03/16 | 2,420 | 2,440 | 2,356 | 2,401 | -33 | -1.4% | 1,209,100 |
2023/03/15 | 2,441 | 2,453 | 2,377 | 2,434 | +43 | +1.8% | 1,493,000 |
2023/03/14 | 2,380 | 2,437 | 2,374 | 2,391 | -25 | -1% | 1,263,700 |
2023/03/13 | 2,410 | 2,441 | 2,362 | 2,416 | -44 | -1.8% | 1,033,600 |
2023/03/10 | 2,499 | 2,568 | 2,427 | 2,460 | -3 | -0.1% | 2,477,000 |
2023/03/09 | 2,417 | 2,469 | 2,404 | 2,463 | +126 | +5.4% | 3,743,100 |
2023/03/08 | 2,288 | 2,352 | 2,270 | 2,337 | +34 | +1.5% | 843,300 |
2023/03/07 | 2,310 | 2,345 | 2,292 | 2,303 | -19 | -0.8% | 541,800 |
2023/03/06 | 2,360 | 2,363 | 2,315 | 2,322 | -6 | -0.3% | 692,000 |
2023/03/03 | 2,240 | 2,375 | 2,240 | 2,328 | +102 | +4.6% | 1,740,200 |
2023/03/02 | 2,180 | 2,235 | 2,158 | 2,226 | +78 | +3.6% | 847,900 |
2023/03/01 | 2,207 | 2,223 | 2,136 | 2,148 | -58 | -2.6% | 1,000,100 |
2023/02/28 | 2,261 | 2,261 | 2,184 | 2,206 | -5 | -0.2% | 1,141,600 |
2023/02/27 | 2,309 | 2,309 | 2,199 | 2,211 | -137 | -5.8% | 1,940,200 |
2023/02/24 | 2,368 | 2,389 | 2,337 | 2,348 | -23 | -1% | 714,400 |
2023/02/22 | 2,421 | 2,421 | 2,360 | 2,371 | -73 | -3% | 1,069,100 |
2023/02/21 | 2,445 | 2,492 | 2,411 | 2,444 | +10 | +0.4% | 750,100 |
2023/02/20 | 2,478 | 2,478 | 2,413 | 2,434 | -57 | -2.3% | 872,600 |
2023/02/17 | 2,570 | 2,577 | 2,471 | 2,491 | -106 | -4.1% | 1,546,400 |
2023/02/16 | 2,435 | 2,609 | 2,395 | 2,597 | +169 | +7% | 2,191,100 |
2023/02/15 | 2,340 | 2,455 | 2,305 | 2,428 | +79 | +3.4% | 1,327,400 |
2023/02/14 | 2,332 | 2,349 | 2,320 | 2,349 | +30 | +1.3% | 452,600 |
2023/02/13 | 2,326 | 2,347 | 2,291 | 2,319 | -50 | -2.1% | 686,400 |
2023/02/10 | 2,404 | 2,423 | 2,365 | 2,369 | -44 | -1.8% | 514,800 |
2023/02/09 | 2,422 | 2,434 | 2,387 | 2,413 | -24 | -1% | 530,100 |
2023/02/08 | 2,445 | 2,447 | 2,402 | 2,437 | +11 | +0.5% | 353,800 |
2023/02/07 | 2,371 | 2,435 | 2,369 | 2,426 | +57 | +2.4% | 501,200 |
2023/02/06 | 2,426 | 2,429 | 2,364 | 2,369 | -37 | -1.5% | 609,900 |
2023/02/03 | 2,421 | 2,440 | 2,392 | 2,406 | -20 | -0.8% | 692,800 |
2023/02/02 | 2,440 | 2,449 | 2,411 | 2,426 | -21 | -0.9% | 692,700 |
2023/02/01 | 2,475 | 2,519 | 2,439 | 2,447 | -5 | -0.2% | 989,200 |
2023/01/31 | 2,419 | 2,459 | 2,403 | 2,452 | +29 | +1.2% | 603,000 |
2023/01/30 | 2,405 | 2,459 | 2,398 | 2,423 | -16 | -0.7% | 605,100 |
2023/01/27 | 2,430 | 2,457 | 2,382 | 2,439 | -21 | -0.9% | 1,074,700 |
2023/01/26 | 2,445 | 2,502 | 2,431 | 2,460 | +15 | +0.6% | 952,000 |
2023/01/25 | 2,426 | 2,459 | 2,394 | 2,445 | -5 | -0.2% | 807,600 |
401~
450
件表示中 / 4975件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 113,400円 | +197.7% | - | 0.00% | 46.35倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 330,500円 | +3.0% | +27.5% | 2.42% | 20.93倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 222,400円 | +13.6% | +29.2% | 2.07% | 11.54倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 71,300円 | -3.7% | -36.7% | 2.81% | 23.48倍 | 1.54倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム